Perioperative Eltrombopag in Patients With Inherited Thrombocytopenia
Status:
Recruiting
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to estimate the response to eltrombopag based on platelet count
increase above a safety level of 80 G/L and lack of requirement for pre-, per- and
post-operative administration of platelet concentrates (PC) for performing elective invasive
acts at mild or high bleeding risk,in selected patients with inherited thrombocytopenia (IT).
Phase:
Phase 2
Details
Lead Sponsor:
University Hospital, Toulouse
Collaborators:
French network for inherited hemorragic diseases National Reference Centre for Platelet Pathologies